Navigation Links
Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
Date:10/25/2012

tute for, or superior to, financial measures and consolidated financial results calculated in accordance with GAAP, and you should carefully evaluate our reconciliations to non-GAAP.  We may calculate our non-GAAP financial measures differently from similarly titled measures used by other companies.  Therefore, our non-GAAP financial measures may not be comparable to those used by other companies.  We have described the reconciliations of each of our non-GAAP financial measures described above to the most directly comparable GAAP financial measures.

We use these non-GAAP financial measures, and in particular non-GAAP operating loss, for internal managerial purposes and incentive compensation for senior management because we believe such measures are one important indicator of the strength and the operating performance of our business.  Analysts and investors frequently ask us for this information.  We believe that they use these measures to evaluate the overall operating performance of companies in our industry, including as a means of comparing period-to-period results and as a means of evaluating our results with those of other companies.

Our non-GAAP operating loss during the three months ended September 30, 2012 and 2011 was approximately $163,000 and $837,000, respectively.  Our non-GAAP operating loss during the six months ended September 30, 2012 and 2011 was approximately $724,000 and $1.8 million, respectively.  The decrease in non-GAAP operating loss for the three and six months ended September 30, 2012 over the corresponding period a year ago is attributed to the increase in net sales and gross profit percent, which more than offset the increase in operating spending.Expense AdjustmentsThree Months EndedGAAPShare-based  ExpenseDepreciationAmortization of IntangiblesNon-GAAPSeptember 30, 2012Gross Profit

$4,935,000

$8,000

$9,000$4,952,000% of net sales

86.4%86.7%Opera
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Uroplasty To Participate In Two Upcoming Conferences
2. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
3. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
4. Uroplasty To Present At The JMP Securities Healthcare Conference
5. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
6. Uroplasty Announces Product Development and New Clinical Trial Initiatives
7. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
8. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2012
9. Zimmer Holdings, Inc. Reports Third Quarter 2012 Financial Results
10. Mylan Reports a 51% Increase in Third Quarter 2012 Adjusted Diluted EPS to $0.83
11. ViroPharma Incorporated Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, The ... support that prevents ankle sprains by cushioning the ankle ... fits securely around the outside of any shoe type ... comfort while still offering protection against sprains. With customers ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
(Date:1/23/2015)... Africa , Jan. 23, 2015   Leatt Corporation ... personal protective equipment for all forms of sports, including ... Leatt-Brace® neck brace, announced today that the UISP Lega ... now requires all riders to wear a neck brace ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3
... LONDON, Oct. 5, 2011 SV Life Sciences ("SVLS") today announced ... Dreismann joins SVLS with more than 26 years of experience ... very excited to welcome Dr. Dreismann to SVLS," said Lutz ... team and focus on investments in the diagnostics space. We ...
... EAST BRUNSWICK, N.J., Oct. 5, 2011 Bluestar ... acquisition of property in York, S.C., where it will establish ... Bluestar Silicones will relocate its two U.S. manufacturing ... a 226,000 square foot building set on 20 acres in ...
Cached Medicine Technology:SV Life Sciences Appoints Veteran Diagnostics Professional Dr. Heiner Dreismann as Venture Partner 2Bluestar Silicones Moves Forward with Growth Plans; Completes Acquisition of Facility in South Carolina 2
(Date:1/22/2015)... January 22, 2015 The City of West Hollywood ... a.m., to commemorate the 42nd anniversary of the Supreme Court decision ... “It’s been 42 years since the Roe vs. Wade decision and ... as present as ever,” said City of West Hollywood Councilmember Abbe ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The Incredible Bulk ... Ben Pakulski to increase lean muscle by up to 30lbs ... caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative ... it is a step-by-step, scientific diet formula that allows the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... The Cystic Fibrosis Foundation announced today that VX-770, an ... in CF, showed promising results in an ongoing Phase ... mutation of CF. The drug is being developed by ... for 14 days showed significant improvements in several key ...
... improved access to health education and benefits for ... seniors in communities across America, ... in Washington, D.C., CVS/pharmacy and the National Council on Aging,(NCOA) ... health and well-being of older Americans. Their joint,"Prescription for Better ...
... Recognizes Visionary Advocate, LOS ANGELES, March 27 ... Gregg Gonsalves has been selected as the,first-ever recipient of ... An AIDS activist for 17 years, Gonsalves has played ... and improve access to,lifesaving drugs. He is currently based ...
... women die from breast cancer each year because current ... fail to stem the disease, warns Breast Cancer Campaign ... research published today, 56 of the UKs most influential ... and priorities for the greatest potential impact on patients. ...
... Poll: Teens Still Feel Targeted By Tobacco Advertising and ... Kids across Virginia,will rally against tobacco on April ... the 13th annual Kick Butts Day, sponsored by the,Campaign ... the,nation (for a list of local events, go to, ...
... VANCOUVER, March 27 /PRNewswire-FirstCall/ - CRH Medical Corporation,(CRM:TSX-V) announced ... in Denver, CO. This Center is the Company,s first ... CRH has targeted for expansion. The,opening of the Denver ... According to the National Institute of Health, the ...
Cached Medicine News:Health News:Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770 2Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 2Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 3Health News:AIDS Activist Gregg Gonsalves Receives $100,000 Leadership Award 2Health News:AIDS Activist Gregg Gonsalves Receives $100,000 Leadership Award 3Health News:Too many women still dying from breast cancer, says charity 2Health News:Virginia Kids 'Kick Butts' on April 2 2Health News:Virginia Kids 'Kick Butts' on April 2 3Health News:CRH Medical Corporation opens new center in Denver, Colorado 2
Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic ointment is a multiple dose anti-infective steroid combination in sterile ointment form for topical applications....
... version of the Neuro-MEP. Permanent ... certainty. Using of unique ERG-electrodes and ... for lead electrodes fixation. Detailed patients' ... to the patient's age. Input and ...
... Standard 21" is the ... high luminance 21" monitor. It ... well suited for all kinds ... groups. The refractive camera is ...
Cannula and irrigation extension. Overall Length 150 mm (6.25"). Light Curve....
Medicine Products: